Supplementary Data from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Supplementary Data from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie et al.
Topics
Glycosylation and Glycoproteins Research
article
Supplementary Data from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie, John R. Sanchez, Jessica D. Johnson, Sridharan Jayamohan, Yang Wang, Suryavathi Viswanadhapalli, Manjeet K. Rao, Gangadhara R. Sareddy, Panneerdoss Subbarayalu, K.V. Dileep, Ratna K. Vadlamudi, Alondra L. Rodriguez Sanchez
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Supplementary Data from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer — Dong Liang, Hareesh B. Nair, et al. · (2025) | TGRS Research Map | TGRS